# Yangzhou Liberty Pharmaceuticals Co. Ltd. – FDA Inspection, Sep 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/yangzhou-liberty-pharmaceuticals-co-ltd/baf39705-3d06-4c9a-9d88-bf06cec2f8b6
Source feed: FDA_Inspections

> FDA inspection 1219530 of Yangzhou Liberty Pharmaceuticals Co. Ltd., September 15, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219530
- Company Name: Yangzhou Liberty Pharmaceuticals Co. Ltd.
- Inspection Date: 2023-09-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1028357 - 2017-09-15](https://www.keypedia.com/records/fda_inspections/yangzhou-liberty-pharmaceuticals-co-ltd/19729e89-d65e-44f4-8740-a97e291b3c8c)
- FDA Inspection 927841 - 2015-04-24

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/patty-p-kaewussdangkul/1f0961fc-216e-4580-830a-56a76c0e7cea)

Company: https://www.keypedia.com/companies/yangzhou-liberty-pharmaceuticals-co-ltd/71823610-ebd0-4493-876d-9694002c8995

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c